CoronaVac, previously known as PiCoVacc, is a SARS-CoV-2 purified, inactivated, and adsorbed vaccine candidate developed by SinoVac Biotech Corporation[A219758]. It was developed by propagating the SARS-CoV-2 CN2 strain inside Vero Cells and inactivating it w…